# The fatigue spectrum in a community-based long haul COVID cohort

**Authors:** Isabelle V. Carter, Anna May, Isabella C. Hsieh, Juliane Torer, David Rosenberg, Kingman P. Strohl

PMC · DOI: 10.1007/s11325-025-03512-y · Sleep & Breathing = Schlaf & Atmung · 2026-01-31

## TL;DR

This study examines fatigue in long haul COVID patients, finding that 21% meet criteria for chronic fatigue syndrome, while brain fog is a common but distinct symptom.

## Contribution

The study identifies a spectrum of fatigue in long haul COVID patients and highlights the distinct nature of brain fog.

## Key findings

- 21% of patients with fatigue met ME/CFS criteria, while 79% did not.
- Brain fog was common across all groups but showed distinct features.
- Fatigue severity was higher in patients with primary fatigue complaints.

## Abstract

In a Long Haul COVID referral clinic we describe the primary presentations of fatigue according to the CDC 2015 criteria for myalgic encephalitis/chronic fatigue syndrome (ME/CFS).

Between September 2021 and April 2022, 277 patients (61% women, 54 yrs: range 18–90 yrs) presented an average of 10 months after an acute COVID-19 infection (22% hospitalized). The clinical data were analyzed to conpare those with or without a primary or co-primary complaint of fatigue, subdivided as meeting ME/CFS criteria or not.

209 (73.5%) people (64% women) presented with fatigue. The Fatigue Severity Score was 5.33 (out 7) in those with 5.31 (SD1.54) vs. without 4.43 (SD1.65) a primary fatigue complaint (p > 0.001). Anxiety (58% vs. 38%, p < 0.02) and any psychiatric diagnosis (66% vs. 44%%, p < 0.01), but not depression itself, were overrepresented in those with Fatigue and ME/CFS. Those with prior managed sleep conditions did not increase risk for fatigue presentation. Of those with fatigue and an elevated FSS, 45/209 (21.9%) met criteria for ME/CFS. In those not meeting these criteria, associated ME/CFS symptoms were less consistent. Physical functioning by ECOG (1.88 (0.78) and 26% >2) did correlate with fatigue status. Depression was present (PHQ9 12.34 (5.95) with 63% >10) to a moderate or higher degree and was different with fatigue complaints. Brain fog (51.9%) was similar among the three categories, and correlated with FSS > 4, ECOG, and depression.

The fatigue phenotype in those presenting with it as a primary complaint comprises 21% meeting ME/CFS criteria and 79% which do not. In all the Long Haul COVID presentations. brain fog had separate, distinguishing features. Post-COVID fatigue is a spectrum which will confound clinical trials.

The online version contains supplementary material available at 10.1007/s11325-025-03512-y.

## Full-text entities

- **Genes:** DOCK3 (dedicator of cytokinesis 3) [NCBI Gene 1795] {aka MOCA, NEDIDHA, PBP}
- **Diseases:** Orthostatic intolerance (MESH:D054971), conditions (MESH:D020763), ICD-DM (OMIM:252500), neurocognitive symptoms (MESH:D012816), inability (MESH:C564980), fibromyalgia (MESH:D005356), cancer (MESH:D009369), MDD (MESH:D003865), neuropathy (MESH:D009422), sleepiness (MESH:D000077260), sleep apnea (MESH:D012891), diabetes Type 2 (MESH:D003924), Fatigue (MESH:D005221), psychiatric (MESH:D001523), migraine (MESH:D008881), dyspnea (MESH:D004417), Brain structural damage (MESH:D001925), sleep health (OMIM:603663), myalgia (MESH:D063806), tinnitus (MESH:D014012), thyroid, liver, renal, or blood disorders (MESH:D017093), concentration difficulty (MESH:C567712), anemia (MESH:D000740), TBI (MESH:D000070642), infection (MESH:D007239), FSS (MESH:C535483), rash (MESH:D005076), narcolepsy (MESH:D009290), inflammation (MESH:D007249), Generalized Anxiety Disorder (MESH:C000726808), COVID acute infection (MESH:D000094024), cardiac (MESH:D006331), Anxiety (MESH:D001007), Insomnia (MESH:D007319), brain dysfunction (MESH:D001927), snoring (MESH:D012913), arthritis (MESH:D001168), exertional malaise (MESH:C564288), ageusia (MESH:D000370), GI distress (MESH:D012128), Anxiety disorder (MESH:D001008), Sleep disorders (MESH:D012893), Conversion Disorder (MESH:D003291), liver function abnormalities (MESH:D056486), heart failure (MESH:D006333), liver disease (MESH:D008107), ME/CSF (MESH:D002559), cardiovascular or (MESH:D002318), cognitive impairment (MESH:D003072), dizziness (MESH:D004244), word finding difficulty (MESH:D009461), Brain Fog (MESH:D005222), Headache (MESH:D006261), SARS (MESH:D045169), post (MESH:D000094025), COVID (MESH:D000086382), poor (MESH:D009123), Depression (MESH:D003866), Memory disturbances (MESH:D008569), atrial fibrillation (MESH:D001281)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12860841/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12860841/full.md

---
Source: https://tomesphere.com/paper/PMC12860841